Publications
Health Economics: An Introduction to Economic Evaluation
1 September 2013
Since the second edition of this publication appeared in 2002, economic evaluation of new medical technologies as a basis for decisions about their use has expanded…
The challenges and economics of drug development in 2022
1 July 2013
Based on OHE’s 50th anniversary conference, this publication captures the views of thought leaders from around the world about the scientific and economic climate for drug…
A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients
1 July 2013
Significantly increases of wealth and health in the Western world over the past 50 years do not appear to have produced an equivalent increase in societal…
What constitutes credible evidence of effectiveness
1 June 2013
In this monograph based his remarks at the 19th OHE Annual Lecture, Professor Sir Michael Rawlins examines the standards of proof required to show the effectiveness…
Exploring the link between health and wealth in decision making
1 May 2013
Is the Link Between Health and Wealth Considered in Decision Making? Results from a Qualitative Study Is the Link Between Health and Wealth Considered in Decision…
Multi-Criteria Decision Analysis to Value Orphan Medicines
1 May 2013
The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using…
Projecting Expenditure on Medicines in the NHS
4 January 2013
Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines is easy to separate out, however, this sector continues…
The Effect of Free Personal Care for the Elderly on Informal Caregiving
1 February 2013
Forecasters predict that the population of people aged 65+ in the UK will double by 2050, constituting a quarter of the total population. This will seriously…
Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity
1 December 2012
The UK Government is proposing to include “burden of illness” criteria in its scheme for value based pricing of branded medicines, potentially according higher rewards to medicines…